Bicocca Open Archive

Logo unimib boa
LANDONI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.831
EU - Europa 6.328
AS - Asia 3.904
SA - Sud America 166
AF - Africa 37
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 12
Totale 23.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.677
SG - Singapore 1.685
IT - Italia 1.512
RU - Federazione Russa 1.202
IE - Irlanda 925
HK - Hong Kong 908
SE - Svezia 898
CN - Cina 752
DE - Germania 716
UA - Ucraina 324
VN - Vietnam 241
GB - Regno Unito 197
FI - Finlandia 143
BR - Brasile 137
CA - Canada 132
ID - Indonesia 88
AT - Austria 77
FR - Francia 76
IN - India 71
NL - Olanda 71
DK - Danimarca 40
TR - Turchia 39
ES - Italia 23
BE - Belgio 22
SK - Slovacchia (Repubblica Slovacca) 22
IR - Iran 17
JP - Giappone 16
CH - Svizzera 15
MX - Messico 15
AU - Australia 14
PH - Filippine 13
RO - Romania 11
CL - Cile 10
BG - Bulgaria 8
CZ - Repubblica Ceca 8
EU - Europa 8
KG - Kirghizistan 8
MA - Marocco 8
PL - Polonia 8
ZA - Sudafrica 8
BD - Bangladesh 6
KR - Corea 6
NG - Nigeria 6
PK - Pakistan 6
PT - Portogallo 6
TH - Thailandia 6
CO - Colombia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
RS - Serbia 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
GR - Grecia 4
HR - Croazia 4
MN - Mongolia 4
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BO - Bolivia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
CR - Costa Rica 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
KE - Kenya 2
LU - Lussemburgo 2
MK - Macedonia 2
SA - Arabia Saudita 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GT - Guatemala 1
IM - Isola di Man 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
PA - Panama 1
PF - Polinesia Francese 1
Totale 23.296
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.071
Fairfield 1.397
Singapore 1.153
Woodbridge 964
Hong Kong 894
Dublin 890
Houston 750
Ashburn 749
Wilmington 678
Chandler 636
Seattle 503
Cambridge 500
Santa Clara 495
Princeton 442
New York 428
Frankfurt am Main 402
Milan 385
Jacksonville 288
Dearborn 277
Lawrence 197
Altamura 167
Beijing 126
Boardman 126
San Diego 117
Nanjing 101
Helsinki 91
Shanghai 91
Dong Ket 89
Andover 82
Jakarta 81
Moscow 74
Rome 74
Hamburg 73
Guangzhou 68
Toronto 63
London 61
Fremont 59
Vienna 54
Nuremberg 45
Lachine 41
Norwalk 33
Los Angeles 32
Council Bluffs 31
Lissone 30
Falls Church 29
Nanchang 28
Bologna 25
Shenyang 25
Munich 23
Chicago 22
Hebei 22
Monza 22
Bratislava 21
Genova 21
Turin 21
Tianjin 20
Pune 19
Brussels 18
Hangzhou 18
Shenzhen 18
Ottawa 17
Brescia 16
Jinan 16
Florence 15
Washington 15
Mountain View 14
São Paulo 13
Zhengzhou 13
Palermo 12
Desio 11
Kunming 11
Naples 11
Adana 10
Carugate 10
Dallas 10
Düsseldorf 10
Huizen 10
Kilburn 10
Padova 10
Changsha 9
Cinisello Balsamo 9
Jiaxing 9
Bishkek 8
Groningen 8
Lappeenranta 8
Lodi 8
Redmond 8
Sacramento 8
Santiago 8
Sestri Levante 8
Amsterdam 7
Edmonton 7
Garbagnate Milanese 7
Hanoi 7
Hefei 7
Ludhiana 7
Manila 7
Menlo Park 7
Messina 7
Paris 7
Totale 16.655
Salva come PNG Salva come JPEG
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 494
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 383
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 310
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 302
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 298
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 273
Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220) 270
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 265
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 238
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 230
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 222
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 213
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 205
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer 204
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 198
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 190
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 182
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 179
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 178
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions 177
Uterine leiomyosarcoma: analysis of treatment failures and survival 176
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 175
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 167
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 159
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 158
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 157
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 155
Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series 155
Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy 154
The clinical significance of the tumor marker CA-125 154
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 153
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer 152
Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB 151
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 150
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 149
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 149
Chemo-conization in early cervical cancer 148
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 147
European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer 146
The clinical implementation of primary HPV screening 144
Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience 141
Endometrial stromal sarcoma: analysis of treatment failures and survival 140
Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series 140
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 139
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 139
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 137
Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center 136
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients 135
Fertility-Sparing Options in Young Women with Cervical Cancer 135
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 135
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 133
Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit 133
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: A randomized controlled trial 132
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study 132
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 132
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 128
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 128
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study 127
Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a Major surgery: A randomized controlled trial 124
Teniposide in refractory ovarian cancer: a phase II study 122
Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy 122
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience 121
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity 120
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 119
Phase II study of the platinum analog TNO-6 in patients with advanced ovarian cancer 118
Borderline ovarian cancer 118
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 118
Repair of the Perineal Defect After Radical Vulvar Surgery: Direct Closure Versus Skin Flaps Reconstruction: A Retrospective Comparative Study 116
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 115
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 115
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 113
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 113
Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages 108
DNA interstrand cross-links induced by cis-dichlorodiammine platinum in ovarian cancer cells growing in primary culture 108
Effect of tamoxifen on steroid hormone receptors and creatine kinase activity in human endometrial carcinoma 107
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 107
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 106
The role of restaging borderline ovarian tumors: single institution experience and review of the literature 103
Feasibility of transabdominal cardiophrenic lymphnode dissection in advanced ovarian cancer: Initial experience at a tertiary center 103
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan 102
Surveillance procedures for patients with cervical carcinoma a review of the literature 102
Poorly differentiated synovial sarcoma of the vagina: a case report and a clinical literature review 102
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 101
Eviscerazione pelvica 101
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM) 101
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis 100
Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay 100
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay 100
Robotic approach for cervical cancer: comparison with laparotomy: a case control study 99
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin 99
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 97
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort 97
Mitozolomide activity on human cancer cells in vitro 97
Flow cytometric analysis of DNA content in human ovarian cancers 96
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 94
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer 93
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 92
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 92
How to address sexual problems in female cancer patients 92
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) 91
Totale 14.976
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020775 0 0 0 0 0 0 0 0 0 380 287 108
2020/20213.921 243 242 409 278 328 357 380 375 320 298 285 406
2021/20222.661 162 322 368 170 160 164 127 169 129 199 212 479
2022/20233.348 477 912 250 221 228 561 58 172 254 32 90 93
2023/20242.974 73 63 180 123 432 688 553 67 310 68 52 365
2024/20255.808 408 1.160 600 381 662 332 405 242 920 698 0 0
Totale 24.381